US4252783A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Reducing fluorescent background in fluorescent immunoassays
Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1979-06-18
•
Granted: 1981-02-24
•
Expires: 1999-06-18
Abstract
Abstract Background fluorescence which interferes with the measurement of an analyte in fluorescent immunoassays in serum samples is substantially diminished by treating the serum sample with a sufficient amount of a peroxidic compound, either organic or inorganic, for a time sufficient to reduce the background fluorescence contributed by serum components. The peroxidic compound is readily quenched, without adversely affecting the assay composition.
Inventors
- 👤 Jean Kam
- 👤 Robert A. Yoshida
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 13:38
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/582; Y; Y10; Y10S; Y10S435/00; Y10S435/968; Y10S436/00; Y10S436/80; Y10S436/825
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
68 words
In a method for determining the presence of an analyte in a serum sample, wherein the amount of analyte is related to the amount of fluorescence from said sample medium, the improvement which comprises: contacting said analyte containing serum sample in a medium at a pH of at least about 6.5 with a peracid in an amount sufficient to substantially reduce the endogenous fluorescence of said serum sample.
Claim 2
Dependent Claim
68 words
In a method for determining the presence of an analyte in a serum sample, wherein the amount of analyte is related to the amount of fluorescence from said sample medium, the improvement which comprises: contacting said analyte containing serum sample in a medium at a pH of at least about 6.5 with a peracid in an amount sufficient to substantially reduce the endogenous fluorescence of said serum sample.
Claim 3
Dependent Claim
11 words
A method according to claim 1, wherein said peracid is organic.
Claim 4
Dependent Claim
11 words
A method according to claim 1, wherein said peracid is inorganic.
Claim 5
Dependent Claim
102 words
In an immunoassay method for determining the presence of an analyte in a serum sample, where a fluorescent label is employed bound to either a ligand or receptor and the amount of fluorescence is related to the amount of the sample, the improvement which comprises: contacting said serum sample with from about 0.01 mmole to 10 mmole of peracid per ml of serum at a pH of at least about 6.5 for a time sufficient to substantially reduce fluorescence endogenous to said serum; and destroying excess peracid with a chemical reductant, to provide a sample for analysis having substantially reduced endogenous fluorescence.
Claim 6
Dependent Claim
102 words
In an immunoassay method for determining the presence of an analyte in a serum sample, where a fluorescent label is employed bound to either a ligand or receptor and the amount of fluorescence is related to the amount of the sample, the improvement which comprises: contacting said serum sample with from about 0.01 mmole to 10 mmole of peracid per ml of serum at a pH of at least about 6.5 for a time sufficient to substantially reduce fluorescence endogenous to said serum; and destroying excess peracid with a chemical reductant, to provide a sample for analysis having substantially reduced endogenous fluorescence.
Claim 7
Dependent Claim
38 words
A method according to claim 4, wherein said peracid is a percarboxylic acid, the pH is in the range of about 7 to 8.5, and the amount of peracid is from about 0.01 to 1 mmole per ml.
Claim 8
Dependent Claim
11 words
A method according to claim 5, wherein said peracid is peracetate.
Claim 9
Dependent Claim
38 words
A method according to claim 4, wherein said peracid is an inorganic acid, the pH is in the range of about 8.5 to 10.5, and the peracid is present in from about 0.05 to 10 mmole per ml.
Claim 10
Dependent Claim
12 words
A method according to claim 7, wherein said inorganic acid is persulfate.
Claim 11
Independent Claim
28 words
A method according to any of claims 4 to 8, wherein said sample having substantially reduced endogenous fluorescence is treated with α-cyclodextrin prior to measurement of said analyte.
References Cited (Backward Citations)
US3689633A
Cited
US4121975A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-02-24 | 1984-08-25 | 1985-02-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-02-24 | 1988-08-25 | 1989-02-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-02-24 | 1992-08-25 | 1993-02-24 | $7700.00 | Window Closed / Lapsed |